Seguimiento de transacciones de insiders en los distintos mercados.
| Suscríbase para acceder a todos los datos. | ||||||
|---|---|---|---|---|---|---|
| Compañía | Sector empresarial | Capitalización de mercado ($) | # Compras netas de insiders | Valor neto de la compra ($) | % de flotación comprada | % de acciones en manos de insiders |
|
|
Pharmaceuticals & Medical Research | Nano (9.1mn) | -1–5 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.1mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (9.1mn) | 0 | No hay actividad | — | — |
|
|
Healthcare Services | Nano (9.1mn) | 0 | No hay actividad | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (9.1mn) | 0 | No hay actividad | — | 50%+ | |
| Pharmaceuticals & Medical Research | Nano (9.1mn) | 0 | No hay actividad | — | 50%+ | |
|
|
Healthcare Services | Nano (9.0mn) | 0 | No hay actividad | — | 15–50% |
|
|
Healthcare Services | Nano (9.0mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (8.9mn) | 0 | No hay actividad | — | 50%+ |
|
|
Healthcare Services | Nano (8.8mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (8.7mn) | 0 | No hay actividad | — | — |
|
|
Pharmaceuticals & Medical Research | Nano (8.5mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (8.4mn) | 0 | No hay actividad | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (8.4mn) | 1–5 | $100K–$1M | 15–50% | 0–15% | |
|
|
Healthcare Services | Nano (8.4mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 0 | No hay actividad | — | 15–50% |
|
|
Healthcare Services | Nano (8.3mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (8.2mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.2mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.2mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.1mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (7.9mn) | 1–5 | $100K–$1M | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (7.8mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.8mn) | 0 | No hay actividad | — | 50%+ |
|
|
Healthcare Services | Nano (7.8mn) | 1–5 | < $100K | 0–15% | 50%+ |
| Pharmaceuticals & Medical Research | Nano (7.6mn) | 0 | No hay actividad | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (7.4mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (7.4mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.4mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No hay actividad | — | — |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (7.2mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (7.2mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.2mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (7.1mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (7.1mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (7.0mn) | 0 | No hay actividad | — | 50%+ |
|
|
Healthcare Services | Nano (6.9mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.9mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.8mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.8mn) | 1–5 | $100K–$1M | 15–50% | 15–50% |
|
|
Healthcare Services | Nano (6.8mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (6.8mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.7mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.7mn) | 0 | No hay actividad | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (6.6mn) | 0 | No hay actividad | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (6.5mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (6.5mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (6.4mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.4mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (6.3mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.3mn) | 1–5 | < $100K | 0–15% | 15–50% |
| Pharmaceuticals & Medical Research | Nano (6.2mn) | 0 | No hay actividad | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (6.2mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.2mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (6.2mn) | 1–5 | $100K–$1M | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (6.1mn) | 0 | No hay actividad | — | — |
|
|
Pharmaceuticals & Medical Research | Nano (6.1mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (6.1mn) | -1–5 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.1mn) | 1–5 | $100K–$1M | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (6.0mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (6.0mn) | 0 | No hay actividad | — | 50%+ |
| Pharmaceuticals & Medical Research | Nano (6.0mn) | 0 | No hay actividad | — | 0–15% | |
|
|
Healthcare Services | Nano (6.0mn) | 0 | No hay actividad | — | — |
|
|
Pharmaceuticals & Medical Research | Nano (6.0mn) | 1–5 | $100K–$1M | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.9mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.9mn) | -1–5 | -< $100K | -0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (5.9mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.9mn) | 1–5 | < $100K | 0–15% | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (5.9mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (5.8mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (5.8mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (5.8mn) | 0 | No hay actividad | — | 15–50% |
|
|
Healthcare Services | Nano (5.8mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.8mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.7mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.7mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (5.7mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (5.6mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.6mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (5.6mn) | 0 | No hay actividad | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (5.5mn) | 0 | No hay actividad | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (5.5mn) | 0 | No hay actividad | — | 0–15% |
|
|
Healthcare Services | Nano (5.5mn) | 0 | No hay actividad | — | — |
|
|
Healthcare Services | Nano (5.5mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (5.5mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (5.4mn) | 0 | No hay actividad | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (5.3mn) | 0 | No hay actividad | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (5.3mn) | 0 | No hay actividad | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (5.2mn) | 0 | No hay actividad | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (5.2mn) | 0 | No hay actividad | — | 0–15% | |
|
|
Healthcare Services | Nano (5.2mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (5.2mn) | 0 | No hay actividad | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (5.1mn) | 0 | No hay actividad | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (5.1mn) | 0 | No hay actividad | — | 15–50% |
|
|
Healthcare Services | Nano (5.0mn) | 0 | No hay actividad | — | 0–15% |